Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CS1 targeted chimeric antigen receptor-modified T cells for treatment of AL amyloidosis

CS1 targeted chimeric antigen receptor-modified T cells for treatment of AL amyloidosis

US Patent 11744862 · Granted Sep 5, 2023

Estimated economic value: $5,060,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CAR for treatment of HIV infection2025
CS1 targeted chimeric antigen receptor-modified T cells2025
Use of triplex CMV vaccine in CAR T cell therapy2025
Administration of engineered T cells for treatment of cancers in the central ner2025
Oncolytic virus expressing a car T cell target and uses thereof2025
TAG72 targeted chimeric antigen receptor modified T cells for treatment of TAG722025
Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy2024
Use of endogenous viral vaccine in chimeric antigen receptor T cell therapy2024
T cells for expression of chimeric antigen receptors and other receptors2024
CD123-specific chimeric antigen receptor redirected t cells and methods of their2024
Intelligent multi-rotor rescue thrower and control method thereof2023
CS1 targeted chimeric antigen receptor-modified T cells2023